Influence of the coronavirus disease-2019 pandemic on breast cancer treatment

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 is a multisystemic inflammatory syndrome that has threatened the health of vulnerable populations worldwide. The most severe effects are seen in the elderly and in immunocompromised patients, leading to increased mortality and complications. Breast cancer is the most common type of cancer. With the availability and awareness of early breast screening, immediate therapy is possible once a patient is diagnosed; however, in the coronavirus disease-2019 (COVID-19) outbreak, breast cancer patients faced a unique situation where treatment was possibly delayed. To decrease the risk of infection and mortality in patients with solid organ tumors, strategies such as screening for COVID-19 and triaging of surgical patients have been implemented and international guidelines and vaccination guidelines have also been published. Methods: This case series descriptive, retrospective study of nine female patients aged 45–69 years was conducted from February 2020 to May 2021. Results: Herein, we highlight that it is possible to perform elective surgeries safely in breast cancer patients during a pandemic by implementing COVID-19 risk assessment strategies and using hospital facilities and precautions to avoid the spread of COVID-19. There was no transmission of COVID-19 in any of our patients during the preoperative, intraoperative, postoperative, and follow-up periods. Conclusion: The best method for reducing the risk of infection among breast cancer patients includes advocating for a safer standard care by implementing risk assessment strategies and following strict infection control procedures.